Facility Evaluation Report

On 06/15/2023, Licensing Program Analysts (LPAs) Arielle Pascua and Christina Valerio arrived unannounced to this facility to conduct a case management visit. LPAs were greeted by staff member (SM), Norma Borgus and explained the purpose of the visit. LPA Pascua asked for SM Borgus to go ahead and call the Facility Designated Administrator (FDA), Julian Hawes to inform him that CCL was present. It was at this time that LPAs learned that FDA Hawes was unable to come to the facility. LPAs continued the visit with SM Borgus.

Current Census was 4. A brief interview with SM Borgus was conducted.

The purpose of this visit is to follow up on the documentation that was requested by the department on a previous case management visit on 06/02/2023 and was due to LPA Pascua's email on 06/08/2023. As of the date of this visit, 06/15/2023, the department has not received documentation.

The following deficiencies were cited per Title 22 Division 6 of the California Code of Regulations.

An exit interview was conducted and a copy of this report was provided to the facility via email and an electronic email read receipt confirms receiving these documents.